Dasatinib plus Peg‐Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA …
L Roy, JC Chomel, J Guilhot… - British Journal of …, 2023 - Wiley Online Library
Superior rates of deep molecular response (DMR) have been reported with the combination
of tyrosine kinase inhibitors and pegylated‐interferon‐alpha (Peg‐IFN) in patients with …
of tyrosine kinase inhibitors and pegylated‐interferon‐alpha (Peg‐IFN) in patients with …
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA …
L Roy, JC Chomel, J Guilhot… - British Journal of …, 2022 - europepmc.org
Superior rates of deep molecular response (DMR) have been reported with the combination
of tyrosine kinase inhibitors and pegylated-interferon-alpha (Peg-IFN) in patients with newly …
of tyrosine kinase inhibitors and pegylated-interferon-alpha (Peg-IFN) in patients with newly …
Dasatinib plus Peg-Interferon alpha 2b combination in newly diagnosed chronic phase chronic myeloid leukaemia: Results of a multicenter phase 2 study (DASA …
L Roy, JC Chomel, J Guilhot… - British journal of …, 2023 - pubmed.ncbi.nlm.nih.gov
Superior rates of deep molecular response (DMR) have been reported with the combination
of tyrosine kinase inhibitors and pegylated-interferon-alpha (Peg-IFN) in patients with newly …
of tyrosine kinase inhibitors and pegylated-interferon-alpha (Peg-IFN) in patients with newly …